Chronic Subdural Hematoma, Caused by Disseminated Intravascular Coagulation and/or Anticoagulation Therapy, after COVID-19

Chronic subdural hematoma (CSDH) typically develops in the supratentorial region in elderly patients. We treated a case of unilateral supratentorial and bilateral infratentorial CSDH, whereby the patient had a coronavirus disease 2019 (COVID-19) infection combined with disseminated intravascular coa...

Descripción completa

Detalles Bibliográficos
Autores principales: NOMURA, Yu, NARAOKA, Masato, FUJIWARA, Nozomi, KINOSHITA, Shouhei, YANAGIYA, Keita, SASAKI, Takao, WATANABE, Ryouta, UENO, Kouta, SHIMAMURA, Norihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239695/
https://www.ncbi.nlm.nih.gov/pubmed/35836493
http://dx.doi.org/10.2176/jns-nmc.2021-0425
_version_ 1784737363386171392
author NOMURA, Yu
NARAOKA, Masato
FUJIWARA, Nozomi
KINOSHITA, Shouhei
YANAGIYA, Keita
SASAKI, Takao
WATANABE, Ryouta
UENO, Kouta
SHIMAMURA, Norihito
author_facet NOMURA, Yu
NARAOKA, Masato
FUJIWARA, Nozomi
KINOSHITA, Shouhei
YANAGIYA, Keita
SASAKI, Takao
WATANABE, Ryouta
UENO, Kouta
SHIMAMURA, Norihito
author_sort NOMURA, Yu
collection PubMed
description Chronic subdural hematoma (CSDH) typically develops in the supratentorial region in elderly patients. We treated a case of unilateral supratentorial and bilateral infratentorial CSDH, whereby the patient had a coronavirus disease 2019 (COVID-19) infection combined with disseminated intravascular coagulation 2 months earlier. The patient had not experienced any head trauma before the onset of the CSDH. The postoperative course was uneventful, and the patient experienced no neurological deficit. We propose that we should be aware not only of acute ischemic or hemorrhagic diseases after COVID-19 infection but also of chronic subdural hematoma caused by coagulopathy after a COVID-19 infection.
format Online
Article
Text
id pubmed-9239695
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Japan Neurosurgical Society
record_format MEDLINE/PubMed
spelling pubmed-92396952022-07-13 Chronic Subdural Hematoma, Caused by Disseminated Intravascular Coagulation and/or Anticoagulation Therapy, after COVID-19 NOMURA, Yu NARAOKA, Masato FUJIWARA, Nozomi KINOSHITA, Shouhei YANAGIYA, Keita SASAKI, Takao WATANABE, Ryouta UENO, Kouta SHIMAMURA, Norihito NMC Case Rep J Case Report Chronic subdural hematoma (CSDH) typically develops in the supratentorial region in elderly patients. We treated a case of unilateral supratentorial and bilateral infratentorial CSDH, whereby the patient had a coronavirus disease 2019 (COVID-19) infection combined with disseminated intravascular coagulation 2 months earlier. The patient had not experienced any head trauma before the onset of the CSDH. The postoperative course was uneventful, and the patient experienced no neurological deficit. We propose that we should be aware not only of acute ischemic or hemorrhagic diseases after COVID-19 infection but also of chronic subdural hematoma caused by coagulopathy after a COVID-19 infection. The Japan Neurosurgical Society 2022-06-15 /pmc/articles/PMC9239695/ /pubmed/35836493 http://dx.doi.org/10.2176/jns-nmc.2021-0425 Text en © 2022 The Japan Neurosurgical Society https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives International License.
spellingShingle Case Report
NOMURA, Yu
NARAOKA, Masato
FUJIWARA, Nozomi
KINOSHITA, Shouhei
YANAGIYA, Keita
SASAKI, Takao
WATANABE, Ryouta
UENO, Kouta
SHIMAMURA, Norihito
Chronic Subdural Hematoma, Caused by Disseminated Intravascular Coagulation and/or Anticoagulation Therapy, after COVID-19
title Chronic Subdural Hematoma, Caused by Disseminated Intravascular Coagulation and/or Anticoagulation Therapy, after COVID-19
title_full Chronic Subdural Hematoma, Caused by Disseminated Intravascular Coagulation and/or Anticoagulation Therapy, after COVID-19
title_fullStr Chronic Subdural Hematoma, Caused by Disseminated Intravascular Coagulation and/or Anticoagulation Therapy, after COVID-19
title_full_unstemmed Chronic Subdural Hematoma, Caused by Disseminated Intravascular Coagulation and/or Anticoagulation Therapy, after COVID-19
title_short Chronic Subdural Hematoma, Caused by Disseminated Intravascular Coagulation and/or Anticoagulation Therapy, after COVID-19
title_sort chronic subdural hematoma, caused by disseminated intravascular coagulation and/or anticoagulation therapy, after covid-19
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239695/
https://www.ncbi.nlm.nih.gov/pubmed/35836493
http://dx.doi.org/10.2176/jns-nmc.2021-0425
work_keys_str_mv AT nomurayu chronicsubduralhematomacausedbydisseminatedintravascularcoagulationandoranticoagulationtherapyaftercovid19
AT naraokamasato chronicsubduralhematomacausedbydisseminatedintravascularcoagulationandoranticoagulationtherapyaftercovid19
AT fujiwaranozomi chronicsubduralhematomacausedbydisseminatedintravascularcoagulationandoranticoagulationtherapyaftercovid19
AT kinoshitashouhei chronicsubduralhematomacausedbydisseminatedintravascularcoagulationandoranticoagulationtherapyaftercovid19
AT yanagiyakeita chronicsubduralhematomacausedbydisseminatedintravascularcoagulationandoranticoagulationtherapyaftercovid19
AT sasakitakao chronicsubduralhematomacausedbydisseminatedintravascularcoagulationandoranticoagulationtherapyaftercovid19
AT watanaberyouta chronicsubduralhematomacausedbydisseminatedintravascularcoagulationandoranticoagulationtherapyaftercovid19
AT uenokouta chronicsubduralhematomacausedbydisseminatedintravascularcoagulationandoranticoagulationtherapyaftercovid19
AT shimamuranorihito chronicsubduralhematomacausedbydisseminatedintravascularcoagulationandoranticoagulationtherapyaftercovid19

Ejemplares similares